Immunovant Inc
IMVT
Market Cap$2.87B
Close$
$4.71
71.9% downside
Current Fair Value
71.9% downsideOvervalued by 71.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.87 Billion |
|---|---|
| Enterprise Value | $2.17 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.73 |
| Beta | 0.61 |
| Outstanding Shares | 151,574,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.14 |
|---|---|
| PEG | -14.86 |
| Price to Sales | - |
| Price to Book Ratio | 4.19 |
| Enterprise Value to Revenue | 13563.51 |
| Enterprise Value to EBIT | -5.17 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
ESG Score
No data